| Product Code: ETC7652705 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Graft Versus Host Disease Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Graft Versus Host Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Graft Versus Host Disease Market - Industry Life Cycle |
3.4 Israel Graft Versus Host Disease Market - Porter's Five Forces |
3.5 Israel Graft Versus Host Disease Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Israel Graft Versus Host Disease Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.7 Israel Graft Versus Host Disease Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 Israel Graft Versus Host Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of graft versus host disease (GVHD) cases in Israel |
4.2.2 Technological advancements in GVHD treatment options |
4.2.3 Rising investments in healthcare infrastructure in Israel |
4.3 Market Restraints |
4.3.1 High treatment costs associated with GVHD therapies |
4.3.2 Limited awareness and understanding of GVHD among healthcare professionals and patients in Israel |
5 Israel Graft Versus Host Disease Market Trends |
6 Israel Graft Versus Host Disease Market, By Types |
6.1 Israel Graft Versus Host Disease Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Graft Versus Host Disease Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Israel Graft Versus Host Disease Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.1.4 Israel Graft Versus Host Disease Market Revenues & Volume, By ATG Therapies, 2021- 2031F |
6.1.5 Israel Graft Versus Host Disease Market Revenues & Volume, By IL2R? (CD25) Inhibitors, 2021- 2031F |
6.1.6 Israel Graft Versus Host Disease Market Revenues & Volume, By TNF? Inhibitors, 2021- 2031F |
6.1.7 Israel Graft Versus Host Disease Market Revenues & Volume, By Other Biologics, 2021- 2031F |
6.1.8 Israel Graft Versus Host Disease Market Revenues & Volume, By Calcineurin Inhibitors, 2021- 2031F |
6.2 Israel Graft Versus Host Disease Market, By Treatment Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Graft Versus Host Disease Market Revenues & Volume, By Prophylaxis GVHD, 2021- 2031F |
6.2.3 Israel Graft Versus Host Disease Market Revenues & Volume, By Chronic GVHD, 2021- 2031F |
6.2.4 Israel Graft Versus Host Disease Market Revenues & Volume, By Acute GVHD, 2021- 2031F |
6.3 Israel Graft Versus Host Disease Market, By End Users |
6.3.1 Overview and Analysis |
6.3.2 Israel Graft Versus Host Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Israel Graft Versus Host Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.4 Israel Graft Versus Host Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 Israel Graft Versus Host Disease Market Import-Export Trade Statistics |
7.1 Israel Graft Versus Host Disease Market Export to Major Countries |
7.2 Israel Graft Versus Host Disease Market Imports from Major Countries |
8 Israel Graft Versus Host Disease Market Key Performance Indicators |
8.1 Patient survival rates post-GVHD treatment |
8.2 Adoption rate of novel GVHD treatment modalities in Israel |
8.3 Number of research studies and clinical trials focused on GVHD in Israel |
9 Israel Graft Versus Host Disease Market - Opportunity Assessment |
9.1 Israel Graft Versus Host Disease Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Israel Graft Versus Host Disease Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.3 Israel Graft Versus Host Disease Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 Israel Graft Versus Host Disease Market - Competitive Landscape |
10.1 Israel Graft Versus Host Disease Market Revenue Share, By Companies, 2024 |
10.2 Israel Graft Versus Host Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here